Imaging services provider Diagnostic Health Services of Dallasannounced last week that it has signed an agreement to buy fourhospital-based MRI operations run by Diagnostic Imaging Servicesof Los Angeles. DHS also announced that it has acquired
Imaging services provider Diagnostic Health Services of Dallasannounced last week that it has signed an agreement to buy fourhospital-based MRI operations run by Diagnostic Imaging Servicesof Los Angeles. DHS also announced that it has acquired UltrasoundDiagnostic Services, a Phoenix-based provider of ultrasound services.
Diagnostic Imaging Services is owned by Primedex Health Systems,which also operates imaging center chain RadNet and managed-serviceorganization Future Diagnostics. Primedex said in September thatit was "exploring strategic options" for the company,and the Diagnostic Health sale apparently fits that intention(SCAN 10/9/96).
The four MRI operations that Diagnostic Health is buying arebased in southern California and are situated on the grounds ofhospitals, which fits the business model that DHS follows, accordingto chairman and CEO Max Batzer.
"We are not in the freestanding center market,"Batzer said. "Our model is department management. This givesus a chance to enter the department through MRI rather than throughour traditional power alleys of ultrasound and nuclear medicine."
The California operations will also complement Diagnostic Health'sactivity in Nevada and Arizona, the company said. The DIS andUDI acquisitions are expected to add $12 million in annual revenuesto DHS. The UDI deal is complete, while the DIS purchase is expectedto close by March 31. DHS paid $1.1 million in cash and stockfor UDI, but terms of the DIS deal were not disclosed.
Primedex executives declined to comment on whether they willcontinue to divest parts of their company.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.